Steven Ryder
Chief Tech/Sci/R&D Officer en RALLYBIO CORPORATION .
Fortuna: 355 885 $ al 31/03/2024
Perfil
Steven W.
Ryder is currently a Director at Biotechnology Innovation Organization, Director at Levo Therapeutics, Inc., and Chief Medical Officer at Rallybio Corp.
Previously, he served as an Independent Director at Reata Pharmaceuticals, Inc. from 2022 to 2023, Chief Development Officer at Alexion Pharmaceuticals, Inc. from 2013 to 2018, President at American Society of Clinical Psychopharmacology, and President at Astellas Pharma Global Development, Inc. from 2008 to 2013.
He holds a doctorate degree from Icahn School of Medicine at Mount Sinai.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
RALLYBIO CORPORATION
0.51% | 31/03/2024 | 192 370 ( 0.51% ) | 355 885 $ | 31/03/2024 |
Cargos activos de Steven Ryder
Empresas | Cargo | Inicio |
---|---|---|
RALLYBIO CORPORATION | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Director/Board Member | 01/07/2019 |
Antiguos cargos conocidos de Steven Ryder.
Empresas | Cargo | Fin |
---|---|---|
REATA PHARMACEUTICALS, INC. | Director/Board Member | 26/09/2023 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2018 |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | President | 01/04/2013 |
American Society of Clinical Psychopharmacology | President | - |
Formación de Steven Ryder.
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
RALLYBIO CORPORATION | Health Technology |
Empresas privadas | 6 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
American Society of Clinical Psychopharmacology | |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Steven Ryder